Hyloris Pharmaceuticals Email Formats

Biotechnology Research • Ans, Walloon Region, Belgium • 21-50 Employees

Hyloris Pharmaceuticals Email Formats

Hyloris Pharmaceuticals uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@hyloris.com), used 51.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@hyloris.com	51.1%
{first initial}.{last name}	j.doe@hyloris.com	40%
{first initial}.{second initial}{last name}	j.odoe@hyloris.com	4.4%
{second initial}.{last name}	o.doe@hyloris.com	4.4%

Key Contacts at Hyloris Pharmaceuticals

Marissa Berry

Director, Regulatory Strategy

Johan D'Hauw

Finance Director

Sam Scholten

Associate Director Regulatory Affairs – Cmc

Company overview

Headquarters	Boulevard Patience et Beaujonc, N°3/1, Liège, Walloon Region 4000, BE
Phone number	+3220132014
Website	hyloris.com
NAICS	541714
SIC	283
Founded	2012
Employees	21-50
Socials

About Hyloris Pharmaceuticals

We are a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare needs and deliver relevant improvements for patients, healthcare professionals and payors. We have built a broad proprietary pipeline of complex value-added reformulated and repurposed products that have the potential to offer significant advantages over currently available medications. Today, we have two, partnered commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a novel, dual mode-of-action non-opioid analgesic for the treatment of post-operative pain. Our development strategy of reformulating and repurposing approved pharmaceuticals primarily utilises the 505(b)(2) regulatory pathway in the U.S. and similar pathways in other countries, which are specifically designed for pharmaceutical agents for which the safety and efficacy have already been established. This focused strategy can dramatically reduce the clinical burden required to bring a product to market, and significantly shortens the development timelines while also reducing costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Vice President

Employees by Department

Hyloris Pharmaceuticals has 26 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Hyloris Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-05-01	14	$16,600,000
2023-07-08	9	$1,100,000

Funding Insights

$17,700,000

Total funding amount

$1,100,000

Most recent funding amount

Number of funding rounds

Hyloris Pharmaceuticals Tech Stack

Discover the technologies and tools that power Hyloris Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Site Kit

Analytics

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

Hyloris Pharmaceuticals is located in Ans, Walloon Region, BE.

You can reach Hyloris Pharmaceuticals at +3220132014.

Hyloris Pharmaceuticals was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

Hyloris Pharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Hyloris Pharmaceuticals has raised a total of $17,700,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Hyloris Pharmaceuticals

Marissa Berry

Director, Regulatory Strategy

Johan D'Hauw

Finance Director

Sam Scholten

Associate Director Regulatory Affairs – Cmc

4.8

40,000 users